A Case Report: Limitation of Mouth Opening in Dermatomyositis

개구장애를 동반한 피부근염 환자 증례

  • Kim, Hye-Kyung (Department of Oral Medicine, School of Dentistry, Dankook University) ;
  • Kim, Ki-Suk (Department of Oral Medicine, School of Dentistry, Dankook University) ;
  • Kim, Mee-Eun (Department of Oral Medicine, School of Dentistry, Dankook University)
  • 김혜경 (단국대학교 치과대학 구강내과학교실) ;
  • 김기석 (단국대학교 치과대학 구강내과학교실) ;
  • 김미은 (단국대학교 치과대학 구강내과학교실)
  • Received : 2010.03.30
  • Accepted : 2010.04.24
  • Published : 2010.06.30

Abstract

Dermatomyositis (DM) is an idiopathic inflammatory connective tissue disorder and a systemic autonomic immune disease which shows a progressive muscle weakness and characteristic rash. It is identified by a characteristic rash accompanying, or more often preceding muscle weakness. Pathognomonic skin lesions are a blue-purple discoloration on the upper eyelids with edema (heliotropic rash), a flat red rash on the face and upper trunk, and erythema of the knuckles with a raised violaceous scaly eruption (Gottron's papule). The myopathy represents inflammatory and degenerative changes primarily affecting proximal muscles. DM often involves GI tract and respiratory system with as risk of 15-25% internal malignancy. It's managed with sun protection since muscle weakness as well as a rash could be aggravated by sun exposure. Systemic corticosteroid is an initial therapy and other immunosuppressive agent has been used as alternatives. Facial muscles are unaffected and masticatory muscles are rarely affected in DM. We present trismus close to muscle contracture in a patient with DM. Therefore, it needs continuous mouth-opening exercise to prevent progressive muscle contracture and to ensure normal mouth opening.

피부근염은 특발성의 염증성 결합조직 질환으로서 점진적인 근육의 쇠약과 특징적인 피부 발진의 증상을 보이는 전신적 자가 면역 질환의 일종이며 근력 약화와 함께 나타나거나 흔히 선행하는 특징적 발진에 의해 진단된다. 가장 특징적인 피부증상은 상안검의 부종과 함께 나타나는 푸르면서 보라색 발진인 heliotrophic rash, 안면부와 상부 흉부의 넓적하고 붉은 발진 (flat red rash), 피부의 인설(scaling)현상을 나타내는 손가락 관절(knuckle)부위의 두드러진 Gottron's papules (violaceous scaly eruption)등 이다. 근육 증상으로 주로 근위부 사지 근육의 약화를 동반한 근육의 염증성 및 퇴행성 변화를 보인다. 피부 근염은 종종 소화기계 (gastrointestinal tract)와 호흡기계 (respiratory system)를 침범하며 15%~25%에서 악성변화를 보인다. 치료는 피부증상뿐 아니라 근육 증상도 악화시킬 수 있는 자외선에 대한 노출을 피하고 일차적으로 전신적 corticosteroid를 사용하며 증상이 심하거나 steroid에 반응이 없을 때 다른 면역억제제를 사용할 수 있다. 피부근염에서 안면근은 침범되지 않으며 저작근의 이환 역시 거의 없다. 본 증례를 통해 피부근염을 앓고 있는 환자에서 개구장애가 발생할 수 있으며, 이는 근경축과 유사한 양상을 보임을 알 수 있었다. 따라서 피부근염 환자에서 발생할 수 있는 개구장애는 회복이 어려울 수 있으므로, 점진적으로 개구량이 줄어드는 것을 막고 정상적인 개구량을 확보 할 수 있도록 지속적인 개구운동 등의 치료가 필요하다고 사료된다.

Keywords

References

  1. Kasper et al. Harrison's principles of internal medicine. 16th ed.-vol.2. 2005. McGrow-Hill, p.2540-2545.
  2. Jeffrey P. Callen, Robert L. Wortmann, Dermatomyositis. Clinics in Dermatology 2006;24:363-373. https://doi.org/10.1016/j.clindermatol.2006.07.001
  3. Marie I, Hatron PY, Hachulla E, Wallaert B, Michon -Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 1998;25:1336-1343.
  4. Pautas E, Cherin P, Piette JC et al. Features of polymyositis and dermatomyositis in the eldery: a case-control study. Clin Exp Rheumatol 2000;18: 241-244. https://doi.org/10.1007/s100510070054
  5. Brennan MT, Patronas NJ, Brahim JS et al. Bilateral condylar resorption in dermatomyositis. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:446-451. https://doi.org/10.1016/S1079-2104(99)70244-1
  6. Callen JP. Dermatomyositis. Lancet 2000;355:53-57. https://doi.org/10.1016/S0140-6736(99)05157-0
  7. Plotz PH, Rider LG, Targoff IN, Raben N, O' Hanlon TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995;122:715-724. https://doi.org/10.7326/0003-4819-122-9-199505010-00010
  8. Targoff IN. Dermatomyositis and polymyositis. Curr probl Dermatol 1991;3:131-180. https://doi.org/10.1016/1040-0486(91)90009-S
  9. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7 and 403-7 [two part articles]. https://doi.org/10.1056/NEJM197502132920706
  10. Wortmann RL. Idiopathic inflammatory diseases of muscle. In: Weisman ML, Weinblatt ME, Louie JS, editors. Treatment of the rheumatic diseases. PHILADELPHIA, PA: W.B. Saunders Co.; 2001.p.390-402.
  11. Spiera R, Kagen L. Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol 1998;10:556-561. https://doi.org/10.1097/00002281-199811000-00008
  12. Marie I, Hatron PY, Hachulla E, Wallaert B, Michon -Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 1998;25:1336-1343.
  13. Selva-O'Callaghan A, Labrador-Horillo M, Munoz- Gall X et al. polymyositis/dermatomyositisassociated lung disease: analysis of a series of 81 patients. Lupus 2005;14:534-542. https://doi.org/10.1191/0961203305lu2158oa
  14. Pautas E, Cherin P, Piette JC et al. Features of polymyositis and dermatomyositis in the eldery: a case-control study. Clin Exp Rheumatol 2000;18: 241-244. https://doi.org/10.1007/s100510070054
  15. Peng JC, Sheem TS, Hsu MM. Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases. Arch Otolaryngol Head Neck Surg 1995;121: 1298-1301. https://doi.org/10.1001/archotol.1995.01890110072013
  16. Sinoway PA, Callen JP. Chlorambucil: an effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis. Arthritisrheum 1993;36: 319-324. https://doi.org/10.1002/art.1780360305
  17. Villalba L, Adams EM. Update on therapy for refractory dematomyositis and polymyositis. Curr Opin Rheumatol 1996;8:544-551. https://doi.org/10.1097/00002281-199611000-00008
  18. Gelber AC, Nousari HC, Wigley FM. Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases. J Rheumatol 2000;27:1542-1545.
  19. Vencovsky J, Jarosova K, Machacek S et al. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 2000;29:95-102. https://doi.org/10.1080/030097400750001897
  20. Rowin J, Amato AA, Deisher N, Cursio J, Meriggioli MN. Mycophenolate mofetil in dermatomyositis: is it safe? Neurology 2006;66:1245-1247. https://doi.org/10.1212/01.wnl.0000208416.32471.c0
  21. Cheong WK, Hughes GRV, Norris PG, Hawk JLM. Cutaneous photosensitivity in dermatomyositis. Br J Dermatol 1994; 131:205-208.
  22. Woo TR, Rasmussen J, Callen JP. Recurrent photosensitive dermatitis preceding juvenile dermatomyositis. Pediatr Dermatol 1985;2:207-212. https://doi.org/10.1111/j.1525-1470.1985.tb01054.x
  23. Callen JP. Photodermatitis in a 6-year-old child. Arthritis Rheum 1993;36:1483-1485. https://doi.org/10.1002/art.1780361022
  24. Zuber M, John S, Pfreundschuh M, Gause A. A young woman with a photosensitive pruritic rash on her face and upper trunk. Arthritis Rheum 1996;39:1419-1422. https://doi.org/10.1002/art.1780390822
  25. Callen JP. Photosensitivity in collagen vascular diseases. Semin Cutan Med Surg 1999;18:293-296 https://doi.org/10.1016/S1085-5629(99)80028-5
  26. Mastaglia FL, Garlepp MJ, Philips BA et al. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
  27. Cunningham JD, Lowry LD. Head and Neck manifestations of dermatomyositis-polymyositis. Otolaryngol Head Neck Surg 1985;93:673-677.